Gender Differences in Social Cognition in Patients With Schizophrenia of Recent Diagnosis and Healthy Controls Subjects
1 other identifier
observational
80
1 country
1
Brief Summary
Individuals with schizophrenia have important and persistent deficits in multiple neurocognitive domains as well as in the Social Cognition (SC). SC refers to the mental operations underlying social behavior, and it is understood as a multidimensional construct that comprises emotional processing (EP), social perspective and knowledge, attributional bias and theory of mind (ToM) or mentalizing. Mentalizing and EP skills have been the two most studied subdomains of SC in schizophrenia. Both domains have been found to be impaired in chronic schizophrenia patients as well as in patients in early stages of the illness. In this context, although negative symptoms may play and important role, females seem to perform better than males in ToM and EP tasks, suggesting the presence of gender differences in the SC skills in patients with schizophrenia. However, to our knowledge, there are no studies that have explored the gender-related differences between cognitive and affective ToM and its relationship with the EP performance in schizophrenia patients of recent diagnosis comparing with healthy subjects. In this line, the main objective of this project is to analyze the influence of gender in the cognitive and affective ToM abilities, in a group of patients with schizophrenia in early stages of the illness comparing with healthy subjects. Secondarily, this study pretends to explore the association between EP skills and affective ToM tasks performance in males and females with and without recent diagnosis of schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 8, 2015
CompletedFirst Posted
Study publicly available on registry
October 14, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedJanuary 31, 2018
January 1, 2018
10 months
October 8, 2015
January 29, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Affective Theory of Mind
Measured by: Reading the Mind in the Eyes test (RMET)
Through study completion, an average of 6 months
Cognitive Theory of Mind
Measured by: False belief stories
Through study completion, an average of 6 months
Secondary Outcomes (2)
Emotional Processing
Through study completion, an average of 6 months
Psychosis Symptoms
Through study completion, an average of 6 months
Other Outcomes (2)
Intelligence Quotient (IQ) in schizophrenia groups
Through study completion, an average of 6 months
Intelligence Quotient (IQ) in healthy groups
Through study completion, an average of 6 months
Study Arms (4)
Women schiz.
Women with recent diagnosis of schizophrenia
Men schiz.
Men with recent diagnosis of schizophrenia
Women healthy
Women without diagnosis of schizophrenia or other neurological and/or psychiatric diagnosis
Men healthy
Men without diagnosis of schizophrenia or other neurological and/or psychiatric diagnosis
Interventions
Eligibility Criteria
Females and males with and without schizophrenia of recent diagnosis.
You may qualify if:
- Patients meeting DSM-IV criteria for schizophrenia or schizoaffective disorder with less than 5 years of evolution of the disorder.
- Being an outpatient for at least 4 weeks before the study (clinical stability).
- No changes in the antipsychotic medication during the month before the study.
- Score less than 4 in the P1, P2 and P3 items of the PANSS.
- Score less than 4 in the Calgary Depression Scale.
You may not qualify if:
- Intellectual disability (IQ\<70).
- History of brain damage.
- History of substance abuse (except nicotine or caffeine) during the last 12 months before the study.
- PARTICIPANTS WITHOUT SCHIZOPHRENIA
- Healthy people over 18 years old.
- Sensory impairment: visual or hearing disabilities.
- Intellectual disability (IQ\<70).
- History of neurologic disease.
- History of psychiatric disorder.
- History of substance abuse (except nicotine or caffeine) during the last 12 months before the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Corporació Parc Taulí
Sabadell, Barcelona, 08208, Spain
Related Publications (8)
Abu-Akel A, Bo S. Superior mentalizing abilities of female patients with schizophrenia. Psychiatry Res. 2013 Dec 30;210(3):794-9. doi: 10.1016/j.psychres.2013.09.013. Epub 2013 Oct 5.
PMID: 24103909BACKGROUNDBora E, Pantelis C. Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis. Schizophr Res. 2013 Mar;144(1-3):31-6. doi: 10.1016/j.schres.2012.12.013. Epub 2013 Jan 21.
PMID: 23347949BACKGROUNDBozikas VP, Andreou C. Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust N Z J Psychiatry. 2011 Feb;45(2):93-108. doi: 10.3109/00048674.2010.541418.
PMID: 21320033BACKGROUNDGreen MF, Penn DL, Bentall R, Carpenter WT, Gaebel W, Gur RC, Kring AM, Park S, Silverstein SM, Heinssen R. Social cognition in schizophrenia: an NIMH workshop on definitions, assessment, and research opportunities. Schizophr Bull. 2008 Nov;34(6):1211-20. doi: 10.1093/schbul/sbm145. Epub 2008 Jan 8.
PMID: 18184635BACKGROUNDKohler CG, Turner TH, Bilker WB, Brensinger CM, Siegel SJ, Kanes SJ, Gur RE, Gur RC. Facial emotion recognition in schizophrenia: intensity effects and error pattern. Am J Psychiatry. 2003 Oct;160(10):1768-74. doi: 10.1176/appi.ajp.160.10.1768.
PMID: 14514489BACKGROUNDMesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology. 2009 May;23(3):315-36. doi: 10.1037/a0014708.
PMID: 19413446BACKGROUNDSavla GN, Vella L, Armstrong CC, Penn DL, Twamley EW. Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophr Bull. 2013 Sep;39(5):979-92. doi: 10.1093/schbul/sbs080. Epub 2012 Sep 4.
PMID: 22949733BACKGROUNDNavarra-Ventura G, Fernandez-Gonzalo S, Turon M, Pousa E, Palao D, Cardoner N, Jodar M. Gender Differences in Social Cognition: A Cross-Sectional Pilot Study of Recently Diagnosed Patients with Schizophrenia and Healthy Subjects. Can J Psychiatry. 2018 Aug;63(8):538-546. doi: 10.1177/0706743717746661. Epub 2017 Dec 7.
PMID: 29216439DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sol Fernandez-Gonzalo, PhD
Corporació Parc Taulí
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Neuropsychologist researcher
Study Record Dates
First Submitted
October 8, 2015
First Posted
October 14, 2015
Study Start
September 1, 2015
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
January 31, 2018
Record last verified: 2018-01